Flashpoint Therapeutics introduces a new way to building cancer immunotherapies.
Flashpoint Therapeutics has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in October 2023.
Flashpoint Therapeutics's investors include CS Venture Opportunities Fund, Beta Lab.
Flashpoint Therapeutics is headquartered in Redwood City, United States.
Flashpoint Therapeutics introduces a new way to building cancer immunotherapies.
Flashpoint Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Flashpoint Therapeutics — Funding & Investors." VCBacked, October 25, 2023, https://www.vcbacked.co/company/flashpoint-therapeutics. Accessed November 13, 2026.
VCBacked. (2023). Flashpoint Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/flashpoint-therapeutics
{{cite web |title=Flashpoint Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/flashpoint-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Flashpoint Therapeutics? Request a listing update